The oligosaccharide moieties of vesicular stomatitis virus glycoprotein from virus grown in four different cell lines have been characterized by sequential enzymic degradation followed by ion-exchange chromatography and analytical gel filtration. Whilst the same two peptide sites are glycosylated in all cell lines, the extent of sialylation of the oligosaccharides is, however, a function of the cell line in which the virus is produced. Using specific purified glycosidases for sequential degradation of glycopeptides obtained after Pronase digestion, the oligosaccharide structures from the different host cell lines appear similar. However, differential sensitivity of the glycopeptides to treatment with a partially purified mixture of endo-and exoglycosidases indicates that the oligosaccharide structures are not identical.
INTRODUCTION
The oligosaccharide moieties of enveloped virus glycoproteins are synthesized by host cell-specific glycosyl transferases, whilst the polypeptide portion of the glycoprotein is virus-specific (for review, see Compans & Klenk, 1979) . Analysis of the glycoprotein derived from virus grown in a variety of cell types has indicated differences in the carbohydrate content of enveloped virus glycoproteins (Burge & Huang, 1970; Etchison & Holland, 1974; Keegstra et al., 1975; Sefton, 1976; Burke & Keegstra, 1976; Stollar et al., 1976) . Also Moyer & Summers (1974) observed a difference in the susceptibility of the oligosaccharide moieties of vesicular stomatitis virus (VSV) glycoprotein to an endoglycosidase depending on whether the virus was grown in transformed or non-transformed cells, whilst Schlesinger et al. (1976) and Robertson et al. (1978) have shown that when VSV and Sindbis are grown in lectin-resistant mutants of Chinese hamster ovary cells, which lack specific glycosyl transferases, the virus glycoproteins have altered oligosaccharide structures.
Since VSV productively infects a variety of vertebrate and invertebrate cell types (for review, see Clark, 1979) , rapidly shuts off host cell macromolecular synthesis and codes for the synthesis of a single glycoprotein polypeptide (Mudd & Summers, 1970 ) -the carbohydrate moieties of which have been extensively characterized (Etchison & Holland, 1974; Robertson et al., 1976; Etchison et al., 1977) , the VSV glycoprotein has become widely utilized as a model system for understanding the mechanisms involved in the biosynthesis of mammalian cell glycoproteins (Kornfeld & Kornfeld, 1980) . In this context, it has been presumed or implied in some recent studies that the detailed structure of the VSV oligosaccharides is independent of the host cells and/or the virus serotype. The studies presented here demonstrate both specific and, as yet, unspecified differences in the structure of the oligosaccharide moieties of the VSV glycoprotein obtained from virus grown in four different mammalian cell lines.
METHODS
Most of the following methods, including growth of cells and virus, preparation and digestion of radiolabelled virus glycoprotein, digestion of peptidyloligosaccharides with glycosidases and analyses by ion-exchange and gel filtration chromatography have been described in detail previously (Robertson et al., 1976; Etchison et al., 1977) .
Cells and virus. BHK-21 cells, L929 mouse cells and MDCK epithelial cells were grown as monolayers and HeLa cells as suspension cultures in Eagle's minimum essential medium (MEM) supplemented with 7 % foetal calf serum (Flow Laboratories). The Indiana serotype of VSV was propagated in HeLa cells or BHK-21 cells and purified as described previously (Mudd & Summers, 1970; Grubman & Summers, 1973; Etchison & Holland, 1974) .
Preparation of radiolabelled VSV glyeoprotein. Monolayer cells infected with VSV at I0
p.f.u, per cell were incubated from 2 to 6 h post-infection in the presence of either 10 #Ci/ml [3H]glucosamine (5 to 15 Ci/mmol) or 1 aCi/ml [~4C]glucosamine (46 mCi/mmol) (New England Nuclear) in MEM supplemented with 2 × non-essential amino acids, 2% dialysed foetal calf serum and containing 1% the normal glucose concentration. At 6 h post-infection, the low glucose labelling medium was diluted twofold with standard culture medium. Virus was harvested at 20 h post-infection. HeLa suspension cultures infected with 10 p.f.u, per cell VSV were incubated from 2 to 20 h post-infection in MEM supplemented with 5 % foetal calf serum and containing 10% the normal glucose concentration and 1 aCi/ml [3H]glucosamine (5 to 15 Ci/mmol). Radiolabelled glycoprotein was solubilized from purified virus with Nonidet P40 (NP40) and precipitated by extraction of the NP40 with 2 vol. n-butanol; the precipitated glycoprotein was washed with ethanol to remove residual NP40 and butanol. The glycoprotein was resuspended immediately in the appropriate buffer and extensively digested with TPCKtrypsin (Worthington)or Pronase (Calbiochem).
Glyeosidase digestion of tryptic glyeopeptides and peptidyloligosaceharides. Tryptic glycopeptides and peptidyloligosaccharides resulting from Pronase digestion were digested with 0.1 unit Clostridium perfringens neuraminidase (Sigma, Type IX) in 0.1 M-phosphate buffer pH 5.3, or with Diploeoeeus pneumoniae neuraminidase in 50 mM-tris-HC1 pH 6.5, 1 mM-CaC12 for 16 h at 37 °C. Digestion with Aspergillus niger fl-galactosidase (78 IU/mg protein), A. niger fl-N-acetyl-glucosaminidase (48 IU/mg protein) (both purified from Rhozyme HPI50 concentrate), beef kidney fl-N-acetyl-glucosaminidase (BoehringerMannheim, New York, U.S.A.) or jack bean fl-N-acetyl-glucosaminidase (Sigma) were performed in 0.05 M-citrate-phosphate buffer pH 4.2, using 2 to 5 U/ml of enzyme and incubating at 37 °C for 24 to 48 h. Digestion with a mixture of partially purified endo-and exoglycosidases from D. pneumoniae was performed in 0-05 M-citrate-phosphate buffer pH 6.5, at 37 °C for 24 h.
Ion-exchange chromatography of tryptie glyeopeptides. The [3H] glucosamine-labelled tryptic glycopeptides were analysed on a 20 × 0.9 cm column of DE52 anion-exchange cellulose (Whatman) equilibrated with 50 mM-tris-HC1 pH 8.5, and eluted with a 200 ml gradient of 0 to 0.1 M-NaC1 in 50 mM-tris-HC1 pH 8.5. Fractions (1.8 ml) were collected and radioactivity determined by liquid scintillation counting.
Gel filtration chromatography of peptidyloligosaeeharides. Peptidyloligosaccharides were applied to a 150 x 0.9 cm column of Bio-Gel P6 (BioRad) and eluted with 0.1 M-ammonium acetate pH 6. Fractions (1.3 ml)were collected and analysed directly for radioactivity as above.
RESULTS

Analysis of the glycosylation of the glycoprotein derived from VSV grown in four different
host cells The extent to which host cell glycosyl transferases specify the glycosylation of VSV glycoprotein was examined by comparison of the glycosylation sites and the oligosaccharide structures of glycoprotein derived from virus grown in four different mammalian cell lines. By anion-exchange chromatography of tryptic glycopeptides it has been demonstrated that VSV glycoprotein derived from virus grown in HeLa cells contains two major glycosylation sites (Robertson et al., 1976) . A similar analysis of the tryptic digestion products of glucosamine-labelled glycoprotein reveals the presence of the same two glycosylation sites in the glycoprotein of virus derived from BHK, L929 and MDCK cells (Fig. 1) . The multiple tryptic glycopeptide species present in all four samples result from heterogeneity of the sialic acid content and are converted into one of two major tryptic glycopeptides by treatment with neuraminidase. It has been demonstrated previously by this type of analysis that the glycoprotein of VSV from HeLa cells contains two glycosylation sites and that tryptic glycopeptides Ia, Ib and Ic are forms of TG I containing presumably 1, 2 and 31 residues of sialic acid respectively, and similarly, that tryptic glycopeptides IIa, IIb and IIc are sialylated forms of TG II (Robertson et al., 1976) . The relative peak heights of the sialic acid-containing tryptic glycopeptides provide an estimate of the extent of sialylation and indicate that the VSV glycoproteins derived from the four cell lines contain sialic acid in the order BHK/VSV > MDCK/VSV > L929/VSV >> HeLa/VSV. The relative content of sialic acid of the various glycoproteins cannot be determined by quantifying the amount of sialic acid released from the tryptic glycopeptides after treatment with neuraminidase because of the varying extent to which the different host cells convert radiolabelled glucosamine into sialic acid.
Analysis of the structure of the oligosaccharide moieties of glycoprotein derived from VS V grown in four different host cells
The structure of the oligosaccharide side chains of glycoprotein from virus grown in HeEa, MDCK and L929 cell lines was compared in detail by P6 gel filtration chromatograpfiy of the peptidyloligosaccharides with those derived from BHK/VSV (Fig. 2, 3 and 4 respectively). In all cases the peptidyloligosaccharides elute from the P6 column as a series of peaks labelled So, $1, $2 or S 3 (Fig. 2a , 3 a and 4a) which are converted to a single S a peak after treatment with neuraminidase (Fig. 2 b, 3 b and 4 b) . These data also demonstrate the heterogeneity of sialylation of the VSV glycoprotein. Peaks S 0, S 1, S 2 and S a correspond to structures containing 3, 2, 1 and 0 residues of sialic acid respectively (Etchison et aL, 1977) ; The relative heights of each of the peaks in Fig. 2 (a) , 3 (a) and 4 (a) similarly indicate the extent of sialylation of the four glycoprotein species, i.e. BHK/VSV > MDCK/VSV > L929/VSV >> HeLa/VSV as has been deduced from Fig. 1 . All of the HeLa, MDCK and L929/ VSV-derived sialic acid-containing peptidyloligosaccharides co-elute with the corresponding BHK/VSV species. After neuraminidase treatment, only the HeLa/VSV co-elute with BHK/VSV asialo-peptidyloligosaccharides, the MDCK/VSV and L929/VSV $3 peaks eluting 1 or 2 fractions ahead of BHK/VSV. The P6 elution profiles of the pepticlyloligosaccharides, after removal of sialic acid and the penultimate galactose residues by treatment with neuraminidase and ~galactosidase, are shown in Fig. 2 (c) , 3 (e) and 4 (c). All samples co-elute with the BHK/VSV species as a single peak, although the MDCK/VSV asialo-agalacto-peptidyloligosaccharide peak is broader than the BHK/VSV peak. (In Fig. 2 and 3, sialic acid released by neuraminidase was removed before d!gestion with fl-galactosidase or N-acetyl-glucosaminidase.) The elution profile of the peptidyl- oligosaccharides after removal of the 'branched' N-acetyl-glucosamine residues by treatment with ~-N-acetyl-glucosaminidase is shown in Fig. 2(d), 3(d) and 4(d) . Most of the peptidyloligosaccharides co-elute as non-symmetrical peaks at fraction 126. The peak of radioactivity at fraction 157 is free N-acetyl-glucosamine. The asymmetric elution profile of the asialo-agalacto-aglucosamino-peptidyloligosaccharides appears to be a manifestation of the heterogeneity of fucosylation, the peak of peptidyloligosaccharides at fraction 126 representing structures which lack fucose whilst the structures which elute in the region of fraction 120 contain fucose attached to the N-acetyl-glucosamine residue of the asparaginyl-N-acetyl-glucosaminyl linkage. We have previously shown that the fucose-labelled glycopeptides from BHK/VSV elute slightly ahead of the glucosamine-labelled structures at this stage 
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of sequential degradation (Etchison et al., 1977) . Thus, the distribution of radioactivity between the shoulder at fraction 120 and the peak at fraction 126 may provide a relative measure of the fucose content of the peptidyloligosaccharides. The relative fucose content of HeLa/VSV peptidyloligosaccharides is identical to those derived from BHK/VSV. The L929/VSV peptidyloligosaccharides elute as a symmetrical peak at fraction 126, indicating the absence of any fucose-containing structures, whilst the increased size of shoulder of the MDCK/VSV species indicates an increased relative fucose content. Thus, the fucose content of glycoprotein from virus grown in all four mammalian cell lines is low and decreases in the order MDCK > BHK ~ HeLa > L929. These results are consistent with previous quantitative analyses of the G protein derived from these cell lines (Etchison & Holland, 1974) . Comparing these data with the relative sialic acid content of the various glycoprotein samples, there is no apparent correlation between the sialic acid and the fucose heterogeneity. The co-elution of most of the peptidyloligosaccharides derived from glycoprotein of virus grown in four different mammalian cell lines before and after treatment with specific exoglycosidases indicates a high degree of structural similarity. The difference in relative peak heights of untreated peptidyloligosaccharides reflects the different sialic acid content of all four samples, whilst the earlier elution and greater heterogeneity of MDCK/VSV-derived peptidyloligosaccharides compared with BHK/VSV results, at least in part, from the increased fucose content. In view of the absence of fucose in L929/VSV peptidyl k oligosaccharides, the elution of the L929/VSV S 3 peak ahead of BHK/VSV $3 is unexplained. To further compare the oligosaccharide structures from the four different cell lines, the glucosamine-labelled peptidyloligosaccharides were subjected to digestion by a partially purified mixture of endo-and exoglycosidases from D. pneumoniae. The results of these studies are shown in Fig. 5 . In all cases [3H]glucosamine-labelled glycopeptides from HeLa, MDCK, and L929 cells were mixed with the [~4C]glucosamine-labelled glycopeptides from BHK cells prior to digestion. Fig. 5 (a) shows that the profiles of the digestion products from HeLa/VSV and BHK/VSV glycopeptides are similar; the major difference seen is the not unexpected difference in the sialic acid peak (fraction 147). By contrast, the profile of the MDCK/VSV digestion products shows that a large portion of the peptidytoligosaccharides were resistant to degradation by this enzymic treatment (Fig. 5 b) . The elution position of the resistant structures indicates that these structures are approx, the same size as the asialo-peptidyloligosaccharides ($3). Fig. 5 (c) shows that a portion of the oligosaccharides from L929/VSV are also resistant to this enzymic digestion.
From the elution position of the oligosaccharides resistant to degradation by the endoglycosidase mixture and the apparently complete release of sialic acid, it appears that the peptidyloligosaccharides from MDCK/VSV are partially resistant to the action of the pneumococcus fl-galactosidase. By contrast, it was shown in Fig. 3 that the fl-galactosidase from A. niger removed all the galactose residues. These results suggested the possibility that the difference in the ability of the enzymes to hydrolyse the galactose residues might be due to differences in the sugar linkages (e.g. ill, 3 versus ill, 4) and different specificities of the fl-galact0sidases. If this were the case, we reasoned that the A. niger fl-galactosidase might also cleave the different linkages at different rates. To examine this possibility we incubated Fig. 6 shows that the BHK/VSV glycopeptides were preferentially degraded relative to the MDCK/VSV glycopeptides. This result further emphasizes the apparent differences in the structure of the oligosaccharides and suggests that more detailed studies should reveal specific differences in the linkages of the sugar moieties. Further studies, including methylation analysis, will be needed to specify these differences and those observed for the L929/VSV glycopeptides.
DISCUSSION
We have carried out studies which begin to characterize and define differences in the oligosaccharide structure of the G protein of VSV grown in different host cells. In addition to BHK and HeLa cells, we have analysed the G oligosaccharides of VSV grown in MDCK epithelial cells and mouse L929 cells. We analysed the tryptic glycopeptides of glucosaminelabelled G protein from these cell lines on DEAE-cellulose columns before and after neuraminidase digestion. These studies showed that all four cell lines produced VSV G which differed in their relative sialic acid content, but the same two sites (tryptic peptides) were glycosylated in all four cell lines.
The radiolabelled glycoproteins were also digested with Pronase and analysed on Bio-Gel P6 columns before and after sequential degradation with various exoglycosidases. The results of these studies showed that the glycopeptides from BHK-and HeLa-grown VSV were indistinguishable by gel filtration at each stage of sequential degradation with neuraminidase, galactosidase and glucosaminidase. The glycopeptides from MDCK and L929 cells were very similar to those from BHK and HeLa but slight differences in elution positions were detected at the different stages of degradation. During these studies we noted that the glycopeptides from MDCK cells appeared to be digested more slowly by the exoglycosidases than were those from BHK cells. This is clearly shown in neuraminidase, galactosidase and glucosaminidase under conditions selected to give incomplete digestion. These results clearly show differential digestion by the mixture of glycosidases. However, if the digestion is carried out for longer times, the gel filtration profiles show a single peak of glycopeptide products which differ in elution position by only 1 or 2 fractions.
An even more dramatic difference is seen when the mixed glycopeptides from MDCK-and BHK-grown VSV are digested with a partially purified mixture of endo-and exoglycosidases from pneumococcus. Fig. 5 shows that a large proportion of the glycopeptides from MDCK-grown VSV remain undigested or are only partially digested by the enzyme mixture while those from BHK-grown VSV are almost totally digested to small mol. wt. products. The size of the 'resistant' glycopeptides is approx, the same as those which had been digested previously by neuraminidase alone. This suggests that the pneumococcal galactosidase may not be working on these structures. It is important to note that the sequential exoglycosidase digestion studies and the digestion with a mixture of purified exoglycosidases shown in Fig. 6 are not pneumococcal enzymes (i.e. neuraminidase was from C. perfringens, fl-galactosidase from A. niger and fl-N-acetyl-glucosaminidase from beef kidney or jack bean). The resistant glycopeptides remaining after digestion with the pneumococcus glycosidase mixture are clearly heterogeneous.
Similarly, when [~H]glucosamine-labeUed glycopeptides from VSV grown in L929 cells were mixed with [14C]glucosamine-labelled glycopeptides from VSV grown in BHK cells, and the mixture was digested with the pneumococcus glycosidase mixture, a portion of the L929 glycopeptides was also resistant to digestion under conditions in which the BHK glycopeptides were almost completely digested. Again, a portion of the asialo-glycopeptides was resistant (Fig. 5 c) . The shoulder on the lower mol. wt. side of these resistant asialo-glycopeptides is the same size as the asialo-agalacto-glycopeptides seen in the sequential exoglycosidase digestions. In addition, a peak of partially digested glycopeptides is seen at (approx.) fraction 120. These structures correspond in size to the 'de-branched' oligosaccharide core structures. There is a much lesser amount of partially digested glycopeptides of this size from the BHK-grown VSV glycopeptides. Furthermore, two minor peaks of digestion products, one from BHK-and one from L929-grown VSV glycopeptides, are seen between fractions 125 and 135 in Fig. 5 (c) . These two clearly do not co-elute. This suggests that some of the glycopeptides which were completely digested by the glycosidase mixture may not have had identical structures.
Further studies are needed to define precisely what these apparent structural differences in the VSV G oligosaccharides are. Using the methods developed in the last few years for sequencing radiolabelled oligosaccharides and the prospects of further innovations forthcoming from HPLC analysis of radiolabelled oligosaccharides, as well as NMR analysis of unlabelled oligosaccharides in the 50 to 100 nmol range, it should be possible to provide detailed structural information on the host modification of viral envelope glycoproteins.
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